Scalper1 News
The doctor prescribed first-quarter earnings for a trio of medical-related companies — two performed strongly, the other one’s examination disappointed analysts. Amgen (AMGN)earned $2.48 a share in Q1, up 33% from a year earlier, and crushing by 38 cents the estimates of analysts polled by Thomson Reuters. It was the best gain in 11 quarters. Amgen revenue rose 11.3% to $5.03 billion, beating views of $4.91 billion. Among key drugs: Prolia, which Scalper1 News
Scalper1 News